On January 18 and 19 2018, TargetCaRe ESRs, PIs and partners organizations
representatives met in Haifa for the sixth consortium meeting. The meeting was hosted by
Technion and organized with the support of Technion and Procore. ESRs presented their
progresses. Scientific discussions and mentoring sessions took place as well. The project
entered in its last year, it will be a very challenging time! In addition, the fascinating
location of Haifa, in Israel, gave to the consortium members the opportunity to know more
about local history and culture.
www.targetcare.eu/targetcare-consortium- meeting-in- haifa/
The Province of South Holland has awarded a subsidy of €200,000 to a joint project
between SeraNovo and Percuros, with consultancy from Good Biomarker Sciences. The
project allows SeraNovo to further develop their technology platform, while testing it on
the advanced test Percuros will develop. SeraNovo’s technology allows new medicines to
be absorbed in the human body that previously could not.
CANCER project started in March in Nemi within the H2020 RISE programme 2017. The
consortium of universities, SMEs and associations gathered for the kick-off meeting last 9 th
and 10 th April in the wonderful location of Ruspoli Castel in Nemi to discuss about their
future plans of action. Our aim is to study new immunotherapy approaches to improving
cancer outcome and quality of life (QOL). Follow all our progresses on the project website
or on our Facebook page.
Percuros BV is a biotech company
operating in the area of drug discovery research and optical imaging of pathways. It is working in a number of diverse areas including skeletal biology, stem cell tracking, cardiovascular biology and oncology.
Read more about us